82 related articles for article (PubMed ID: 21031422)
21. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
Fietkau R; Zettl H; Klöcking S; Kundt G
Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
[TBL] [Abstract][Full Text] [Related]
22. Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study.
Samowitz WS; Curtin K; Schaffer D; Robertson M; Leppert M; Slattery ML
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1193-7. PubMed ID: 11097226
[TBL] [Abstract][Full Text] [Related]
23. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic value of the presence of the mutation of the codons 12, 13 and 61 in K-ras oncogene in colorectal cancer].
Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P
Orv Hetil; 1999 Jul; 140(30):1673-9. PubMed ID: 10461447
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
[TBL] [Abstract][Full Text] [Related]
26. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.
Petrowsky H; Sturm I; Graubitz O; Kooby DA; Staib-Sebler E; Gog C; Köhne CH; Hillebrand T; Daniel PT; Fong Y; Lorenz M
Eur J Surg Oncol; 2001 Feb; 27(1):80-7. PubMed ID: 11237496
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
28. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
[TBL] [Abstract][Full Text] [Related]
29. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
30. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence.
Kato M; Ito Y; Kobayashi S; Isono K
Cancer; 1996 Apr; 77(8 Suppl):1729-35. PubMed ID: 8608570
[TBL] [Abstract][Full Text] [Related]
31. The DCC protein and prognosis in colorectal cancer.
Shibata D; Reale MA; Lavin P; Silverman M; Fearon ER; Steele G; Jessup JM; Loda M; Summerhayes IC
N Engl J Med; 1996 Dec; 335(23):1727-32. PubMed ID: 8929264
[TBL] [Abstract][Full Text] [Related]
32. Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR.
Oltedal S; Gilje B; Kørner H; Aasprong OG; Tjensvoll K; Heikkilä R; Smaaland R; Nordgård O
Ann Surg; 2010 Jun; 251(6):1087-91. PubMed ID: 20485143
[TBL] [Abstract][Full Text] [Related]
33. Clinical usefulness of K-RAS mutation detection in colorectal cancer and in surgical margins of the colon.
Okulczyk B; Kovalchuk O; Piotrowski Z; Myśliwiec P; Chyczewski L
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():52-4. PubMed ID: 15638373
[TBL] [Abstract][Full Text] [Related]
34. [Current concepts of prognostic factors for colorectal cancer].
Beliaeva AV; Moiseenko AB; Guliaev AV
Vopr Onkol; 2011; 57(3):279-85. PubMed ID: 21882596
[No Abstract] [Full Text] [Related]
35. The type of K-ras mutation determines prognosis in colorectal cancer.
Cerottini JP; Caplin S; Saraga E; Givel JC; Benhattar J
Am J Surg; 1998 Mar; 175(3):198-202. PubMed ID: 9560119
[TBL] [Abstract][Full Text] [Related]
36. Reliability of K-ras mutational analysis on cytological samples from metastatic colorectal cancer.
Bozzetti C; Negri FV; Naldi N; Nizzoli R; Bortesi B; Zobbi V; Azzoni C; Silini EM; Ardizzoni A
Pathologica; 2011 Jun; 103(3):77-8. PubMed ID: 22007571
[No Abstract] [Full Text] [Related]
37. K-ras gene mutation as an early prognostic marker of colon cancer.
Szpon Ł; Stal A; Zawadzki M; Lis-Nawara A; Kielan W; Grzebieniak Z
Pol Przegl Chir; 2016 Jan; 88(1):15-9. PubMed ID: 27096769
[TBL] [Abstract][Full Text] [Related]
38. [Age-related and clinical-pathogenetic features of colorectal cancer associated with status of K-ras gene].
Beliaeva AV; Ianus GA; Suspithyn EN; Zaĭtseva OA; Iatsuk OS; Moiseenko AB; Guliaev AV; Imianitov EN
Adv Gerontol; 2012; 25(1):72-8. PubMed ID: 22708448
[TBL] [Abstract][Full Text] [Related]
39. [Molecular diagnostic tools in gastroenterology].
Weizsäcker FV; Blum HE
Praxis (Bern 1994); 2002 Dec; 91(49):2139-43. PubMed ID: 12523181
[TBL] [Abstract][Full Text] [Related]
40. K-ras gene mutation as a pathogenetic and diagnostic marker in human cancer.
Fearon ER
J Natl Cancer Inst; 1993 Dec; 85(24):1978-80. PubMed ID: 8246279
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
